Cervical priming in the first trimester: Morphological and biochemical effects of misoprostol and isosorbide mononitrate

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 1, 2009, Pages 43-51

  Radulovic, Nina Vukas ^a   Ekerhovd, Erling ^a   Abrahamsson, Gun ^a   Norström, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical ripening; Misoprostol; Nitric oxide

Indexed keywords

COLLAGEN FIBER; COLLAGEN FIBRIL; GELATINASE B; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; ISOSORBIDE 5 NITRATE; ISOSORBIDE MONONITRATE; MISOPROSTOL; ABORTIVE AGENT; DRUG DERIVATIVE; ISOSORBIDE DINITRATE; ISOSORBIDE-5-MONONITRATE;

ADULT; ARTICLE; CHROMATIN; CLINICAL ARTICLE; DRUG EFFECT; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NEEDLE; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STAINING; SURGICAL ABORTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX RIPENING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PREOPERATIVE CARE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SWEDEN; THERAPEUTIC ABORTION; TREATMENT OUTCOME; ULTRASTRUCTURE; UTERINE CERVIX;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, THERAPEUTIC; ADMINISTRATION, INTRAVAGINAL; ADULT; CERVICAL RIPENING; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; ISOSORBIDE DINITRATE; MICROSCOPY, ELECTRON; MISOPROSTOL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREOPERATIVE CARE; PROBABILITY; STATISTICS, NONPARAMETRIC; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59249087349     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340802585440     Document Type: Article

References (26)

1. Liggins GC. Cervical ripening as an inflammatory reaction. In: Ellwood DA, Anderson ABM, editors. Cervical ripening as an inflammatory reaction clinical and biochemical investigation. Edinburgh: Churchill Livingstone, 1981. pp. 1-9.
2. Norström A. Influence of prostaglandin E2 on the biosynthesis of connective tissue constituents in the pregnant human cervix. Prostaglandins. 1982;23:361-7.
3. Uldbjerg N, Ekman G, Malmström A, Ulmsten U, Wingerup L. Biochemical changes in human cervical connective tissue after local application of prostaglandin E2. Gynecol Obstet Invest. 1983;15:291-9.
4. Kelly RW. Inflammatory mediators and cervical ripening. J Reprod Immunol. 2002;57:217-24.
5. Singh K, Fong YF. Preparation of the cervix for surgical termination of pregnancy in the first trimester. Hum Reprod Update. 2000;6:442-8.
6. Fiala C, Gemzell-Danielsson K, Tang OS, von Hertzen H. Cervical priming with misoprostol prior to transcervical procedures. Int J Gynaecol Obstet. 2007;99(Suppl 2):S168-S71.
7. Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynaecol. 1997;104:1054-7.
8. Facchinetti F, Piccinini F, Volpe A. Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomized controlled trial. Hum Reprod. 2000;15:2224-7.
9. Radulovic N, Norström A, Ekerhovd E. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate. Acta Obstet Gynecol Scand. 2007;86:344-8.
10. Sennström MK, Brauner A, Lu Y, Granström LM, Malmström AL, Ekman GE. Interleukin-8 is a mediator of the final cervical ripening in humans. Eur J Obstet Gynecol Reprod Biol. 1997;74:89-92.
11. Stjernholm-Vladic Y, Stygar D, Mansson C, Masironi B, Akerberg S, Wang H, et al. Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol. 2004;2:74, Cited in PubMed PMID15500686.
12. Yoshida K, Tahara R, Nakayama T, Yanaihara T. Effect of dehydroepiandrosterone sulphate, oestrogens and prostaglandins on collagen metabolism in human cervical tissue in relation to cervical ripening. J Int Med Res. 1993;21:26-35.
13. Rath W, Osmers R, Adelmann-Grill BC, Stuhlsatz HW, Szevereny M, Kuhn W. Biochemical changes in human cervical connective tissue after intracervical application of prostaglandin E2. Prostaglandins. 1993;45:375-84.
14. Rechberger T, Abramson SR, Woessner JF Jr. Onapristone and prostaglandin E2 induction of delivery in the rat in late pregnancy: a model for the analysis of cervical softening. Am J Obstet Gynecol. 1996;175:719-23.
15. Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des. 2003;9:359-80.
16. Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 1994;93:1940-7.
17. Sasaki K, Hattori T, Fujisawa T, Takahashi K, Inoue H, Takigawa M. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem. 1998;123:431-9.
18. Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, et al. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003;9:41-5.
19. Theobald PW, Rath W, Kuhnle H, Kuhn W. Histological and electron-microscopic examinations of collagenous connective tissue of the non-pregnant cervix, the pregnant cervix, and the pregnant prostaglandin-treated cervix. Arch Gynecol. 1982;231:241-5.
20. Uldbjerg N, Ekman G, Malmström A, Sporrong B, Ulmsten U, Wingerup L. Biochemical and morphological changes of human cervix after local application of prostaglandin E2 in pregnancy. Lancet 1981;1:267-8.
21. Ekerhovd E, Weijdegård B, Brännström M, Mattsby-Baltzer I, Norström A. Nitric oxide induced cervical ripening in the human: involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol. 2002;186:745-50.
22. Piccinini F, Fano RA, Volpe A, Facchinetti F. Ripening of the cervix with sodium nitroprusside in nonpregnant women. J Soc Gynecol Investig. 2003;10:438-42.
23. Aronsson A, Ulfgren AK, Stabi B, Stavreus-Evers A, Gemzell-Danielsson K. The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy. Contraception. 2005;72:33-9.
24. Ledingham MA, Denison FC, Riley SC, Norman JE. Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. Hum Reprod. 1999;14:2089-96.
25. Yoshida M, Sagawa N, Itoh H, Yura S, Korita D, Kakui K, et al. Nitric oxide increases matrix metalloproteinase-1 production in human uterine cervical fibroblast cells. Mol Hum Reprod. 2001;7:979-85.
26. Malmström E, Sennström M, Holmberg A, Frielingsdorf H, Eklund E, Malmström L, et al. The importance of fibroblasts in remodelling of the human uterine cervix during pregnancy and parturition. Mol Hum Reprod. 2007;13:333-41.